Olmedipin (Olmesartan Medoxomil, Amlodipine)

Olmesartan medoxomil, the active ingredient in Olmedipin, is an angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It treats hypertension and may be prescribed for adults requiring blood pressure control. GNH USA supplies Olmedipin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmedipin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmedipin combines two antihypertensive agents to lower blood pressure through complementary mechanisms.

- Hypertension: provides effective blood pressure reduction in patients with primary hypertension. - Hypertension with isolated systolic hypertension: improves systolic and diastolic control. - Hypertension in patients who require combination therapy: achieves target BP when monotherapy is insufficient.

Olmedipin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate headache may occur. - Peripheral edema: swelling of the ankles or feet. - Dizziness or light‑headed dizziness. - Flushing of the skin. - Fatigue or tired feeling. - Nausea: occasional upset upset stomach.

Serious or Rare Side Effects: - Angio‑ang ang f      . - Hepatotoxic . - Severe hypotension: marked drop in blood pressure. - Acute kidney injury . - Myocardial infarction . - Hyperkalemia . - Blood disorders . -  etc

Olmedip2   g g g.

-   t   t.

t  \